Noticias y eventos de SL Science Holding Ltd (SLBT)

$1.210

-0.020 (-1.63%)Al cierre

Noticias de SLBT

9.009-27NASDAQ.COM

SL Science Holding Reports Positive Data for Glioblastoma Treatment

9.008-27NASDAQ.COM

SL Science Holding Files New Drug Master File with FDA

9.008-27Newsfilter

SL Science Files New Drug Master File with FDA

9.508-04NASDAQ.COM

Biotech Stocks Surge with Significant Gains

8.507-17Newsfilter

SL Science Showcases γδ T Cell Therapy for Glioblastoma

8.507-14Newsfilter

SL Science Submits Orphan Drug Designation for Brain Cancer Treatment

8.507-10NASDAQ.COM

SL Science Holding Submits Orphan Drug Designation for GBM Therapy

2.007-03NASDAQ.COM

Biotech Companies See Significant Stock Gains

9.506-18Newsfilter

SL Science Reports 2025 Financial Results and Strategic Shift

2.006-16Newsfilter

Biotech Companies Achieve Significant Milestones

Ver más noticias

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.